Boothbay Fund Management, LLC Biotechnology

Boothbay Fund Management, LLC

  • $3.28 Billion
  • Q1 2025

Stock List

Stock Option Type Value Options Held Last Trade Trade History
BPMC
Blueprint Medicines Corp
CALL
$31 Million
350K
Q1 2025
Reduced 26.34%
ACAD
Acadia Pharmaceuticals Inc
CALL
$13.1 Million
787K
Q3 2024
New holding
CORT
Corcept Therapeutics Inc
PUT
$10.5 Million
92.2K
Q3 2024
New holding
BBIO
Bridge Bio Pharma, Inc.
CALL
$6.66 Million
193K
Q1 2025
Reduced 55.41%
CORT
Corcept Therapeutics Inc
CALL
$3.66 Million
32K
Q3 2024
New holding
IMVT
Immunovant, Inc.
PUT
$3.44 Million
125K
Q2 2024
Reduced 0.34%
MRNA
Moderna, Inc.
CALL
$2.84 Million
100K
Q2 2024
New holding
RNA
Avidity Biosciences, Inc.
PUT
$2.56 Million
86.7K N/A
VKTX
Viking Therapeutics, Inc.
CALL
$2.37 Million
98.1K
Q1 2025
New holding
ACLX
Arcellx, Inc.
PUT
$2.35 Million
35.8K N/A
PTGX
Protagonist Therapeutics, Inc
PUT
$1.47 Million
30.3K
Q4 2024
New holding
KYMR
Kymera Therapeutics, Inc.
PUT
$1.43 Million
52.2K
Q2 2022
Closed
RARE
Ultragenyx Pharmaceutical Inc.
CALL
$1.23 Million
34.1K
Q1 2025
Added 20.57%
CAPR
Capricor Therapeutics, Inc.
CALL
$1.22 Million
128K
Q3 2024
New holding
INCY
Incyte Corp
CALL
$1.18 Million
19.5K
Q3 2024
New holding
MLTX
Moon Lake Immunotherapeutics
CALL
$1.11 Million
28.5K N/A
MLTX
Moon Lake Immunotherapeutics
PUT
$1.11 Million
28.5K N/A
RARE
Ultragenyx Pharmaceutical Inc.
PUT
$1.1 Million
30.3K
Q1 2025
Added 20.57%
SRRK
Scholar Rock Holding Corp
CALL
$1.03 Million
32.1K
Q1 2025
Reduced 31.99%
QURE
Uni Qure N.V.
CALL
$1.02 Million
96.2K
Q1 2025
Added 59.65%
SMMT
Summit Therapeutics Inc.
PUT
$964,000
50K
Q1 2025
New holding
KYMR
Kymera Therapeutics, Inc.
CALL
$810,000
29.6K
Q2 2022
Closed
DYN
Dyne Therapeutics, Inc.
CALL
$626,000
59.9K
Q1 2025
New holding
ARCT
Arcturus Therapeutics Holdings Inc.
CALL
$471,000
44.5K
Q1 2025
Reduced 14.37%
SWTX
Spring Works Therapeutics, Inc.
CALL
$441,000
10K
Q1 2025
Added 229.84%
CMPX
Compass Therapeutics, Inc.
PUT
$403,000
212K
Q1 2023
Added 57.3%
CMPX
Compass Therapeutics, Inc.
CALL
$403,000
212K
Q1 2023
Added 57.3%
PRTA
Prothena Corp Public LTD CO
CALL
$366,000
29.6K
Q4 2024
New holding
ALT
Altimmune, Inc.
PUT
$342,000
68.4K
Q1 2023
Added 236.63%
CRVS
Corvus Pharmaceuticals, Inc.
CALL
$311,000
98K
Q2 2022
Closed
IMUX
Immunic, Inc.
CALL
$200,000
184K
Q1 2025
Reduced 43.37%
CELC
Celcuity Inc.
PUT
$121,000
12K N/A
CRVS
Corvus Pharmaceuticals, Inc.
PUT
$45,000
14.4K
Q2 2022
Closed
SAVA
Cassava Sciences Inc
CALL
$24,000
16.1K
Q4 2023
New holding
Filter Shares Options
Track This Portfolio

Track Boothbay Fund Management, LLC Portfolio

Follow Boothbay Fund Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Boothbay Fund Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email